5-fluorouracil promising for vaginal intraepithelial neoplasia

November 21, 2017

(HealthDay)—5-fluorouracil is associated with a 74 percent success rate as the initial treatment modality for high-grade intraepithelial vaginal dysplasia, according to a study published online Nov. 7 in Obstetrics & Gynecology.

Stephen Fiascone, M.D., from Brigham and Women's Hospital in Boston, and colleagues retrospectively reviewed the cases of women referred to a single center for management of high-grade vaginal intraepithelial neoplasia between April 1994 and May 2016 to assess the success rates of 5-fluorouracil, excision, and laser ablation as the initial and secondary management strategies.

The researchers found that 47 patients were treated initially with 5-fluorouracil, 35 were treated with excision, and 22 were treated with laser . The groups were similar demographically. There was no recurrence in 35 women treated with 5-fluorouracil (74 percent), 20 treated with excision (57 percent), or nine treated with (41 percent). Eight of the 13 patients treated with 5-fluorouracil for recurrence did not experience a second . Side effects were reported in nine of 58 (16 percent) ever treated with 5-fluorouracil, most commonly irritation and dyspareunia.

"The optimal treatment strategy for women with recurrent or persistent vaginal intraepithelial neoplasia is unclear from the current literature, and the data presented here show that topical 5-fluorouracil may have an important role in this context, especially given the morbidity associated with repeated vaginal surgeries," the authors write.

Explore further: Abnormal pap posthysterectomy for 30 percent of HIV+ women

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Abnormal pap posthysterectomy for 30 percent of HIV+ women

June 14, 2016
(HealthDay)—About one-in-three HIV-infected women with no prehysterectomy history of abnormal Pap results have abnormal vaginal Pap results after hysterectomy, according to a study published in the July issue of Obstetrics ...

Laser removal may be advantageous for treating precancerous skin lesions

November 21, 2011
Carbon dioxide laser ablation (removal) may have a role as an alternative treatment for a common precancerous skin lesion known as lentigo maligna when surgery or radiation therapy is not feasible, according to a report in ...

FDA approves new pancreatic cancer drug

October 22, 2015
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer.

Staged surgical excision superior for treatment of lentigo maligna

December 9, 2015
(HealthDay)—For patients with lentigo maligna, staged surgical excision is associated with a low rate of recurrence, according to research published online Nov. 30 in the British Journal of Dermatology.

Goal in stage Ia1 cervical cancer is complete excision

December 23, 2014
(HealthDay)—Clear excision margins are important in the management of stage Ia1 squamous cervical cancer, according to research published in the December issue of the American Journal of Obstetrics & Gynecology.

Endometrial ablation doesn't increase cancer risk

August 14, 2017
(HealthDay)—For women in Finland, endometrial ablation is not associated with increased risk of endometrial or breast cancer, according to a study published in the September issue of Obstetrics & Gynecology.

Recommended for you

Why mothers in mainland China, Hong Kong and Taiwan choose cesarean delivery

October 16, 2018
Pregnant women in mainland China, Hong Kong, and Taiwan are more likely to express preference for cesarean section (CS) as their mode of delivery later in pregnancy and postpartum, as compared to early in pregnancy, according ...

Importance of cell cycle and cellular senescence in the placenta discovered

October 15, 2018
Working with researchers from Stanford University and St. Anna Children's Cancer Research, researchers from Jürgen Pollheimer's laboratory at the Medical University of Vienna's Department of Obstetrics and Gynecology have ...

C-section rates have nearly doubled since 2000: study

October 12, 2018
(HealthDay)—The number of women delivering babies via cesarean section has nearly doubled worldwide since 2000, to about 21 percent, new research shows.

Study of nearly 41,000 women who almost died giving birth shows who's most at risk

October 10, 2018
Tens of thousands of American women each year need emergency treatment to save their lives while they deliver their babies, or immediately after. A new study shows how much their risk of a life-threatening birth depends on ...

In childbirth, when to begin pushing does not affect C-section rates

October 9, 2018
More than 3 million women in the United States give birth each year. But obstetricians have differing opinions about when women should begin pushing during labor and whether the timing of pushing increases the likelihood ...

Why single embryo transfer during IVF sometimes results in twins or triplets

October 8, 2018
It has been known for some time that it is better to transfer a single embryo to a woman's womb during assisted reproduction treatment (ART) rather than several embryos in order to avoid a multiple pregnancy and the risks ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.